| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | polysaccharide binding | 3.79e-06 | 31 | 20 | 3 | GO:0030247 | |
| GeneOntologyBiologicalProcess | keratinization | 1.09e-06 | 87 | 19 | 4 | GO:0031424 | |
| GeneOntologyBiologicalProcess | skin development | 1.78e-05 | 373 | 19 | 5 | GO:0043588 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 2.38e-05 | 189 | 19 | 4 | GO:0030216 | |
| GeneOntologyBiologicalProcess | epidermis development | 4.90e-05 | 461 | 19 | 5 | GO:0008544 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 1.16e-04 | 284 | 19 | 4 | GO:0009913 | |
| GeneOntologyBiologicalProcess | liver regeneration | 4.43e-04 | 34 | 19 | 2 | GO:0097421 | |
| HumanPheno | Recurrent lower respiratory tract infections | 4.79e-05 | 288 | 5 | 4 | HP:0002783 | |
| HumanPheno | Recurrent pneumonia | 1.87e-04 | 138 | 5 | 3 | HP:0006532 | |
| Domain | EGF | CNTNAP3 CLEC18B CLEC18C CNTNAP3B CLEC18A LAMC3 CNTNAP5 MASP2 | 6.17e-11 | 235 | 20 | 8 | SM00181 |
| Domain | EGF-like_dom | CNTNAP3 CLEC18B CLEC18C CNTNAP3B CLEC18A LAMC3 CNTNAP5 MASP2 | 9.79e-11 | 249 | 20 | 8 | IPR000742 |
| Domain | EGF_1 | CNTNAP3 CLEC18B CLEC18C CNTNAP3B CLEC18A LAMC3 CNTNAP5 MASP2 | 1.18e-10 | 255 | 20 | 8 | PS00022 |
| Domain | EGF_2 | CNTNAP3 CLEC18B CLEC18C CNTNAP3B CLEC18A LAMC3 CNTNAP5 MASP2 | 1.61e-10 | 265 | 20 | 8 | PS01186 |
| Domain | LCE | 2.25e-09 | 17 | 20 | 4 | PF14672 | |
| Domain | LCE | 2.25e-09 | 17 | 20 | 4 | IPR028205 | |
| Domain | EGF_3 | 3.08e-09 | 235 | 20 | 7 | PS50026 | |
| Domain | SPRR/LCE | 1.93e-08 | 28 | 20 | 4 | IPR026075 | |
| Domain | EGF-like_CS | 2.31e-07 | 261 | 20 | 6 | IPR013032 | |
| Domain | SCP | 4.74e-07 | 15 | 20 | 3 | SM00198 | |
| Domain | - | 4.74e-07 | 15 | 20 | 3 | 3.40.33.10 | |
| Domain | Allrgn_V5/Tpx1 | 4.74e-07 | 15 | 20 | 3 | IPR001283 | |
| Domain | CAP | 4.74e-07 | 15 | 20 | 3 | PF00188 | |
| Domain | CAP_domain | 4.74e-07 | 15 | 20 | 3 | IPR014044 | |
| Domain | FA58C | 1.38e-06 | 21 | 20 | 3 | SM00231 | |
| Domain | FA58C_3 | 1.38e-06 | 21 | 20 | 3 | PS50022 | |
| Domain | FA58C_1 | 1.38e-06 | 21 | 20 | 3 | PS01285 | |
| Domain | FA58C_2 | 1.38e-06 | 21 | 20 | 3 | PS01286 | |
| Domain | F5_F8_type_C | 2.10e-06 | 24 | 20 | 3 | PF00754 | |
| Domain | FA58C | 2.10e-06 | 24 | 20 | 3 | IPR000421 | |
| Domain | Galactose-bd-like | 2.74e-06 | 94 | 20 | 4 | IPR008979 | |
| Domain | FIBRINOGEN_C_2 | 5.11e-06 | 32 | 20 | 3 | PS51406 | |
| Domain | Fibrinogen_a/b/g_C_dom | 5.11e-06 | 32 | 20 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_1 | 5.11e-06 | 32 | 20 | 3 | PS00514 | |
| Domain | LAM_G_DOMAIN | 8.65e-06 | 38 | 20 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.01e-05 | 40 | 20 | 3 | PF02210 | |
| Domain | C-type_lectin_CS | 1.26e-05 | 43 | 20 | 3 | IPR018378 | |
| Domain | LamG | 1.35e-05 | 44 | 20 | 3 | SM00282 | |
| Domain | Laminin_G | 3.12e-05 | 58 | 20 | 3 | IPR001791 | |
| Domain | - | 6.23e-05 | 73 | 20 | 3 | 2.60.120.260 | |
| Domain | C_TYPE_LECTIN_1 | 8.19e-05 | 80 | 20 | 3 | PS00615 | |
| Domain | Lectin_C | 9.47e-05 | 84 | 20 | 3 | PF00059 | |
| Domain | CLECT | 9.47e-05 | 84 | 20 | 3 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 9.81e-05 | 85 | 20 | 3 | PS50041 | |
| Domain | C-type_lectin-like | 1.02e-04 | 86 | 20 | 3 | IPR001304 | |
| Domain | - | 1.45e-04 | 97 | 20 | 3 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 1.54e-04 | 99 | 20 | 3 | IPR016186 | |
| Domain | CTDL_fold | 1.94e-04 | 107 | 20 | 3 | IPR016187 | |
| Domain | Growth_fac_rcpt_ | 5.87e-04 | 156 | 20 | 3 | IPR009030 | |
| Domain | ConA-like_dom | 1.56e-03 | 219 | 20 | 3 | IPR013320 | |
| Domain | - | 4.58e-03 | 95 | 20 | 2 | 2.60.120.200 | |
| Pathway | REACTOME_KERATINIZATION | 8.74e-08 | 217 | 16 | 6 | M27640 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.12e-05 | 129 | 16 | 4 | M27649 | |
| Pubmed | Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity. | 1.63e-10 | 3 | 20 | 3 | 26170455 | |
| Pubmed | 1.63e-10 | 3 | 20 | 3 | 16336259 | ||
| Pubmed | Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. | 1.63e-10 | 3 | 20 | 3 | 33603190 | |
| Pubmed | 5.78e-10 | 22 | 20 | 4 | 15854049 | ||
| Pubmed | 6.50e-10 | 4 | 20 | 3 | 16709836 | ||
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | 6.99e-10 | 23 | 20 | 4 | 11698679 | |
| Pubmed | 9.06e-08 | 16 | 20 | 3 | 17410201 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 31150793 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 26807827 | ||
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | 1.09e-06 | 1031 | 20 | 7 | 16710414 | |
| Pubmed | 1.25e-06 | 37 | 20 | 3 | 22432025 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 29397434 | ||
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 4.71e-06 | 6 | 20 | 2 | 34143959 | |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | 2.38e-05 | 630 | 20 | 5 | 36949045 | |
| Pubmed | 4.25e-05 | 17 | 20 | 2 | 26389685 | ||
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 7.21e-05 | 22 | 20 | 2 | 26494785 | |
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 1.26e-04 | 29 | 20 | 2 | 31491374 | |
| Pubmed | 5.10e-04 | 276 | 20 | 3 | 28319085 | ||
| Interaction | LCE2D interactions | 5.21e-11 | 74 | 19 | 6 | int:LCE2D | |
| Interaction | KRTAP12-4 interactions | 1.17e-09 | 53 | 19 | 5 | int:KRTAP12-4 | |
| Interaction | LCE1C interactions | 7.96e-09 | 77 | 19 | 5 | int:LCE1C | |
| Interaction | KRTAP10-10 interactions | 9.77e-09 | 27 | 19 | 4 | int:KRTAP10-10 | |
| Interaction | LCE2B interactions | 1.03e-08 | 81 | 19 | 5 | int:LCE2B | |
| Interaction | KRTAP5-6 interactions | 2.19e-08 | 94 | 19 | 5 | int:KRTAP5-6 | |
| Interaction | KRTAP9-8 interactions | 2.99e-08 | 100 | 19 | 5 | int:KRTAP9-8 | |
| Interaction | ADAMTSL4 interactions | 3.51e-08 | 217 | 19 | 6 | int:ADAMTSL4 | |
| Interaction | SPRY1 interactions | 5.06e-08 | 111 | 19 | 5 | int:SPRY1 | |
| Interaction | KRTAP10-9 interactions | 6.55e-08 | 241 | 19 | 6 | int:KRTAP10-9 | |
| Interaction | LCE3B interactions | 8.98e-08 | 46 | 19 | 4 | int:LCE3B | |
| Interaction | KRTAP1-5 interactions | 1.07e-07 | 48 | 19 | 4 | int:KRTAP1-5 | |
| Interaction | KRTAP4-2 interactions | 1.21e-07 | 132 | 19 | 5 | int:KRTAP4-2 | |
| Interaction | KRTAP9-3 interactions | 1.62e-07 | 140 | 19 | 5 | int:KRTAP9-3 | |
| Interaction | TRIM42 interactions | 2.21e-07 | 149 | 19 | 5 | int:TRIM42 | |
| Interaction | KRTAP9-2 interactions | 2.21e-07 | 149 | 19 | 5 | int:KRTAP9-2 | |
| Interaction | CYSRT1 interactions | 2.50e-07 | 511 | 19 | 7 | int:CYSRT1 | |
| Interaction | KRTAP5-2 interactions | 3.04e-07 | 62 | 19 | 4 | int:KRTAP5-2 | |
| Interaction | KRTAP12-1 interactions | 3.24e-07 | 63 | 19 | 4 | int:KRTAP12-1 | |
| Interaction | KRTAP5-4 interactions | 3.24e-07 | 63 | 19 | 4 | int:KRTAP5-4 | |
| Interaction | KRTAP4-12 interactions | 3.25e-07 | 161 | 19 | 5 | int:KRTAP4-12 | |
| Interaction | KRTAP6-3 interactions | 3.25e-07 | 161 | 19 | 5 | int:KRTAP6-3 | |
| Interaction | KRTAP10-11 interactions | 3.46e-07 | 64 | 19 | 4 | int:KRTAP10-11 | |
| Interaction | KRTAP5-11 interactions | 3.92e-07 | 66 | 19 | 4 | int:KRTAP5-11 | |
| Interaction | KRTAP5-3 interactions | 3.92e-07 | 66 | 19 | 4 | int:KRTAP5-3 | |
| Interaction | LCE1E interactions | 4.42e-07 | 68 | 19 | 4 | int:LCE1E | |
| Interaction | LCE2A interactions | 4.69e-07 | 69 | 19 | 4 | int:LCE2A | |
| Interaction | LCE1D interactions | 4.97e-07 | 70 | 19 | 4 | int:LCE1D | |
| Interaction | KRTAP5-7 interactions | 5.27e-07 | 71 | 19 | 4 | int:KRTAP5-7 | |
| Interaction | KRTAP4-5 interactions | 6.93e-07 | 76 | 19 | 4 | int:KRTAP4-5 | |
| Interaction | SMCP interactions | 8.11e-07 | 79 | 19 | 4 | int:SMCP | |
| Interaction | LCE4A interactions | 8.53e-07 | 80 | 19 | 4 | int:LCE4A | |
| Interaction | KRTAP4-4 interactions | 8.96e-07 | 81 | 19 | 4 | int:KRTAP4-4 | |
| Interaction | LCE1A interactions | 1.04e-06 | 84 | 19 | 4 | int:LCE1A | |
| Interaction | LCE1B interactions | 1.09e-06 | 85 | 19 | 4 | int:LCE1B | |
| Interaction | LCE2C interactions | 1.25e-06 | 88 | 19 | 4 | int:LCE2C | |
| Interaction | LCE5A interactions | 1.37e-06 | 90 | 19 | 4 | int:LCE5A | |
| Interaction | LCE1F interactions | 1.50e-06 | 92 | 19 | 4 | int:LCE1F | |
| Interaction | KRTAP4-11 interactions | 1.50e-06 | 92 | 19 | 4 | int:KRTAP4-11 | |
| Interaction | KRTAP2-3 interactions | 1.70e-06 | 95 | 19 | 4 | int:KRTAP2-3 | |
| Interaction | KRTAP2-4 interactions | 2.17e-06 | 101 | 19 | 4 | int:KRTAP2-4 | |
| Interaction | ALPP interactions | 4.77e-06 | 123 | 19 | 4 | int:ALPP | |
| Interaction | KRTAP12-2 interactions | 5.59e-06 | 128 | 19 | 4 | int:KRTAP12-2 | |
| Interaction | FBLN1 interactions | 5.76e-06 | 129 | 19 | 4 | int:FBLN1 | |
| Interaction | FUCA2 interactions | 8.56e-06 | 43 | 19 | 3 | int:FUCA2 | |
| Interaction | KRTAP12-3 interactions | 9.41e-06 | 146 | 19 | 4 | int:KRTAP12-3 | |
| Interaction | SPRY2 interactions | 1.10e-05 | 152 | 19 | 4 | int:SPRY2 | |
| Interaction | KRTAP10-1 interactions | 1.13e-05 | 153 | 19 | 4 | int:KRTAP10-1 | |
| Interaction | OTX1 interactions | 1.19e-05 | 155 | 19 | 4 | int:OTX1 | |
| Interaction | RGS17 interactions | 1.20e-05 | 48 | 19 | 3 | int:RGS17 | |
| Interaction | VASN interactions | 1.35e-05 | 160 | 19 | 4 | int:VASN | |
| Interaction | KRTAP10-5 interactions | 1.35e-05 | 160 | 19 | 4 | int:KRTAP10-5 | |
| Interaction | KRTAP10-8 interactions | 2.81e-05 | 401 | 19 | 5 | int:KRTAP10-8 | |
| Interaction | CRCT1 interactions | 3.13e-05 | 66 | 19 | 3 | int:CRCT1 | |
| Interaction | KRTAP5-9 interactions | 3.44e-05 | 203 | 19 | 4 | int:KRTAP5-9 | |
| Interaction | CHIC2 interactions | 4.24e-05 | 73 | 19 | 3 | int:CHIC2 | |
| Interaction | KRTAP1-1 interactions | 4.63e-05 | 219 | 19 | 4 | int:KRTAP1-1 | |
| Interaction | CRP interactions | 4.97e-05 | 77 | 19 | 3 | int:CRP | |
| Interaction | KRTAP3-2 interactions | 5.37e-05 | 79 | 19 | 3 | int:KRTAP3-2 | |
| Interaction | SLC16A8 interactions | 5.53e-05 | 12 | 19 | 2 | int:SLC16A8 | |
| Interaction | KRTAP3-3 interactions | 6.00e-05 | 82 | 19 | 3 | int:KRTAP3-3 | |
| Interaction | POU4F2 interactions | 6.22e-05 | 83 | 19 | 3 | int:POU4F2 | |
| Interaction | KRTAP10-6 interactions | 7.41e-05 | 88 | 19 | 3 | int:KRTAP10-6 | |
| Interaction | CHRD interactions | 9.02e-05 | 94 | 19 | 3 | int:CHRD | |
| Interaction | KRTAP10-7 interactions | 1.43e-04 | 293 | 19 | 4 | int:KRTAP10-7 | |
| Interaction | PCSK5 interactions | 1.52e-04 | 112 | 19 | 3 | int:PCSK5 | |
| Interaction | RGS20 interactions | 1.77e-04 | 118 | 19 | 3 | int:RGS20 | |
| Interaction | TGFB1 interactions | 1.93e-04 | 317 | 19 | 4 | int:TGFB1 | |
| Interaction | IGLL5 interactions | 2.05e-04 | 124 | 19 | 3 | int:IGLL5 | |
| Interaction | SDF2L1 interactions | 2.05e-04 | 322 | 19 | 4 | int:SDF2L1 | |
| Interaction | NTN4 interactions | 2.11e-04 | 23 | 19 | 2 | int:NTN4 | |
| Interaction | CATSPER1 interactions | 2.15e-04 | 126 | 19 | 3 | int:CATSPER1 | |
| Interaction | MTMR8 interactions | 2.49e-04 | 25 | 19 | 2 | int:MTMR8 | |
| Interaction | SCGB1D4 interactions | 2.91e-04 | 27 | 19 | 2 | int:SCGB1D4 | |
| Interaction | HOXA1 interactions | 3.01e-04 | 356 | 19 | 4 | int:HOXA1 | |
| Interaction | CDH16 interactions | 3.14e-04 | 28 | 19 | 2 | int:CDH16 | |
| Interaction | CDC25A interactions | 3.66e-04 | 151 | 19 | 3 | int:CDC25A | |
| Interaction | KRTAP4-1 interactions | 3.85e-04 | 31 | 19 | 2 | int:KRTAP4-1 | |
| Interaction | NOTCH2NLA interactions | 3.89e-04 | 381 | 19 | 4 | int:NOTCH2NLA | |
| Interaction | BTNL2 interactions | 3.95e-04 | 155 | 19 | 3 | int:BTNL2 | |
| Interaction | LILRA5 interactions | 4.11e-04 | 32 | 19 | 2 | int:LILRA5 | |
| Interaction | NECTIN2 interactions | 4.26e-04 | 159 | 19 | 3 | int:NECTIN2 | |
| Interaction | CREB5 interactions | 4.66e-04 | 164 | 19 | 3 | int:CREB5 | |
| Interaction | SPRY3 interactions | 4.92e-04 | 35 | 19 | 2 | int:SPRY3 | |
| Interaction | FBXO2 interactions | 5.18e-04 | 411 | 19 | 4 | int:FBXO2 | |
| Interaction | EDDM3A interactions | 5.50e-04 | 37 | 19 | 2 | int:EDDM3A | |
| Interaction | MACO1 interactions | 5.63e-04 | 175 | 19 | 3 | int:MACO1 | |
| Interaction | ABHD17A interactions | 5.80e-04 | 38 | 19 | 2 | int:ABHD17A | |
| Interaction | NTAQ1 interactions | 6.20e-04 | 431 | 19 | 4 | int:NTAQ1 | |
| Interaction | VWC2L interactions | 6.43e-04 | 40 | 19 | 2 | int:VWC2L | |
| Interaction | KRTAP1-3 interactions | 6.51e-04 | 184 | 19 | 3 | int:KRTAP1-3 | |
| Interaction | SLC39A7 interactions | 6.83e-04 | 187 | 19 | 3 | int:SLC39A7 | |
| Interaction | APOM interactions | 7.43e-04 | 43 | 19 | 2 | int:APOM | |
| Interaction | DNAJB9 interactions | 8.54e-04 | 202 | 19 | 3 | int:DNAJB9 | |
| Interaction | KRTAP17-1 interactions | 9.26e-04 | 48 | 19 | 2 | int:KRTAP17-1 | |
| Interaction | KATNBL1 interactions | 9.26e-04 | 48 | 19 | 2 | int:KATNBL1 | |
| Interaction | PATE1 interactions | 9.64e-04 | 49 | 19 | 2 | int:PATE1 | |
| Interaction | CNTNAP3B interactions | 1.00e-03 | 50 | 19 | 2 | int:CNTNAP3B | |
| Interaction | LY86 interactions | 1.05e-03 | 217 | 19 | 3 | int:LY86 | |
| Interaction | OS9 interactions | 1.08e-03 | 219 | 19 | 3 | int:OS9 | |
| Cytoband | 1q21.3 | 2.32e-07 | 117 | 21 | 4 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 3.14e-05 | 404 | 21 | 4 | chr1q21 | |
| Cytoband | 16q22.1 | 1.16e-03 | 110 | 21 | 2 | 16q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 3.16e-03 | 183 | 21 | 2 | chr16q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 3.54e-03 | 681 | 21 | 3 | chr1p36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | 1.27e-02 | 377 | 21 | 2 | chr21q22 | |
| GeneFamily | Late cornified envelope proteins | 1.24e-09 | 18 | 16 | 4 | 627 | |
| GeneFamily | C-type lectin domain family | 9.00e-06 | 47 | 16 | 3 | 494 | |
| GeneFamily | Keratin associated proteins | 4.09e-03 | 109 | 16 | 2 | 619 | |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP | 5.83e-06 | 49 | 19 | 3 | MM452 | |
| Coexpression | DESCARTES_ORGANOGENESIS_MELANOCYTES | 1.44e-05 | 66 | 19 | 3 | MM3664 | |
| Coexpression | PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3 | 9.39e-05 | 20 | 19 | 2 | M2408 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.94e-04 | 158 | 19 | 3 | MM17063 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INHIBITORY_INTERNEURONS | 2.14e-04 | 30 | 19 | 2 | MM3663 | |
| Coexpression | NABA_ECM_AFFILIATED | 2.41e-04 | 170 | 19 | 3 | M5880 | |
| Coexpression | GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP | 3.82e-04 | 199 | 19 | 3 | M9782 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_12H_BMDC_DN | 3.88e-04 | 200 | 19 | 3 | M3722 | |
| Coexpression | GSE31622_WT_VS_KLF3_KO_BCELL_DN | 3.88e-04 | 200 | 19 | 3 | M8471 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 4.11e-04 | 204 | 19 | 3 | MM966 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_250 | 2.97e-05 | 206 | 19 | 4 | Facebase_ST1_Univ_250 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-method_NA_vs_Ectoderm Differentiated Cells-method_mRNA-Confounder_removed-fold2.0_adjp0.05 | 3.63e-05 | 73 | 19 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-mRNA_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-reprogram_NA_vs_Ectoderm Differentiated Cells-reprogram_OSKM-L-Confounder_removed-fold2.0_adjp0.05 | 3.63e-05 | 73 | 19 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-OSKM-L_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-reprogram_NA_vs_Ectoderm Differentiated Cells-reprogram_OSKM - NLT-Confounder_removed-fold2.0_adjp0.05 | 4.43e-05 | 78 | 19 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-OSKM - NLT_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_100 | 8.75e-05 | 98 | 19 | 3 | PCBC_ECTO_blastocyst_100 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_100 | 9.30e-05 | 100 | 19 | 3 | PCBC_ratio_ECTO_vs_SC_100 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-method_NA_vs_Ectoderm Differentiated Cells-method_plasmid-Confounder_removed-fold2.0_adjp0.05 | 9.86e-05 | 102 | 19 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-plasmid_cfr-2X-p05 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO fibroblast-Confounder_removed-fold2.0_adjp0.05 | 1.52e-04 | 118 | 19 | 3 | PCBC_ratio_ECTO blastocyst_vs_ECTO fibroblast_cfr-2X-p05 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO bone marrow-Confounder_removed-fold2.0_adjp0.05 | 2.68e-04 | 143 | 19 | 3 | PCBC_ratio_ECTO blastocyst_vs_ECTO bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500 | 4.92e-04 | 427 | 19 | 4 | Facebase_ST1_Univ_500 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 6.05e-04 | 189 | 19 | 3 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | skin | 6.30e-04 | 456 | 19 | 4 | skin | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_5 | 8.70e-04 | 49 | 19 | 2 | Facebase_ST1_Univ_500_5 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Lpl-Penk_(Layer_2/3)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.86e-06 | 83 | 21 | 3 | b683c8496474b0df0042f596c9b0ea5916a2ab15 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-05 | 165 | 21 | 3 | 2d01ae5d05fe55f6bebd53a5801c4c1f1544515c | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-05 | 173 | 21 | 3 | 0f9c1d3298e59e6d22bb3306f0f445f490be8bbd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.61e-05 | 185 | 21 | 3 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.61e-05 | 185 | 21 | 3 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.62e-05 | 192 | 21 | 3 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.76e-05 | 193 | 21 | 3 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.76e-05 | 193 | 21 | 3 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.76e-05 | 193 | 21 | 3 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-04 | 199 | 21 | 3 | cf592d93612023a13de21e0fb8c6b13714f9af71 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 21 | 3 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 21 | 3 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.49e-04 | 74 | 21 | 2 | bad24c9251ef44c05f3390073732a467aaeefe1e | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.49e-04 | 74 | 21 | 2 | c68b00cf7d2cec7951b78e2c6710d7770b02566a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.49e-04 | 74 | 21 | 2 | 195fd37345a394c0b60f713bedadf6fd08dc050c | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.49e-04 | 74 | 21 | 2 | 08874e430b4c9fcb2c1758c4178cb0c45671b125 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Neurod2|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.64e-04 | 75 | 21 | 2 | 3bc5df14f21c1c93c2a0fd5fc47bc5d146ba87a2 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Lpl_(Layer_2/3)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.47e-04 | 92 | 21 | 2 | dfe63bb979f0382163955b32909ffab1de37685a | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-7|TCGA-Kidney / Sample_Type by Project: Shred V9 | 9.41e-04 | 97 | 21 | 2 | 88ac93868312c9b57a1b23edc76b5907847d2c1d | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Breast_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.04e-03 | 102 | 21 | 2 | 010b446526c0fdfde45cdc04dc2395cbbe60e820 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B3-5|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.43e-03 | 120 | 21 | 2 | 9d4e630e1d3b9adf94a1884071bfe46edaa3f0c1 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-7|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.53e-03 | 124 | 21 | 2 | c6e0c45e9ac128540baddfeb4599a0d5ec3f14cb | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor-3|TCGA-Testes / Sample_Type by Project: Shred V9 | 1.55e-03 | 125 | 21 | 2 | 5f90de494b53ecce6455034f3ed5dccdbb2c29ca | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-1|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.58e-03 | 126 | 21 | 2 | 8b689886ce35ff798aea603cde9ccb0dc9d1fd03 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.70e-03 | 131 | 21 | 2 | 3cb4b272e28ee9bad6d874f64a7aae18352a6cfb | |
| ToppCell | TCGA-Brain-Recurrent_Tumor-Glioblastoma-Primary_GBM-8|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.73e-03 | 132 | 21 | 2 | 614903874a5304b718737cfb9d86b420592ce271 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Aqp5_Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.83e-03 | 136 | 21 | 2 | 8f5682422ba0b477c1e0700212948457f106cb10 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.83e-03 | 136 | 21 | 2 | feb957df4bff3266cb9a7382b16fc927ae03b9b4 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.91e-03 | 139 | 21 | 2 | 849e4c060c9cf9eb7962caf5b169e72da4d85e70 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.00e-03 | 142 | 21 | 2 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.02e-03 | 143 | 21 | 2 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-03 | 143 | 21 | 2 | 6df16bf0324661cd9707df69cb39f4b5498d6d49 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.02e-03 | 143 | 21 | 2 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.05e-03 | 144 | 21 | 2 | 748f4efc59f7afbce6c497524f36d852b8b1d637 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.11e-03 | 146 | 21 | 2 | 7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.14e-03 | 147 | 21 | 2 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-03 | 147 | 21 | 2 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-03 | 147 | 21 | 2 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | COVID-19_Mild-PLT_3|World / Disease Group and Platelet Clusters | 2.14e-03 | 147 | 21 | 2 | 9d3271aa735ddb6f32ab864d7afcfb0f8754383b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-03 | 147 | 21 | 2 | c0f62ed3312a33921476e89844486e09326485b7 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.17e-03 | 148 | 21 | 2 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.20e-03 | 149 | 21 | 2 | 5293c50b3fb41b1edaf9a97354899bd13770078c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.25e-03 | 151 | 21 | 2 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| ToppCell | TCGA-Kidney|World / Sample_Type by Project: Shred V9 | 2.25e-03 | 151 | 21 | 2 | e31974c0d0a0c644205a0ee6013ab74a09d8a306 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-03 | 151 | 21 | 2 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.37e-03 | 155 | 21 | 2 | 79264ff283e36a059040a5aa9fe7337be694cb52 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-03 | 156 | 21 | 2 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-03 | 156 | 21 | 2 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Lung / Manually curated celltypes from each tissue | 2.40e-03 | 156 | 21 | 2 | 0ea6ca3f38109151a2a4fdf63a4f009929cdcc40 | |
| ToppCell | severe_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 2.46e-03 | 158 | 21 | 2 | 8ab3d8a9b7a1daa890d76dde1d6182af40b70021 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-03 | 158 | 21 | 2 | 32c95c1bc9e50fccd6d06e828f29258fc5e568cb | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.56e-03 | 161 | 21 | 2 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-1|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.56e-03 | 161 | 21 | 2 | 6cacae4a759ace763597ee394cff498dc5d96f74 | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 2.56e-03 | 161 | 21 | 2 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | Influenza_Severe-gd_T|World / Disease group and Cell class | 2.56e-03 | 161 | 21 | 2 | b3cdaed4d58d57e3c5dbc904a09388f3bf949407 | |
| ToppCell | droplet-Fat-Scat-18m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-03 | 163 | 21 | 2 | b1a38985d0560dbc6ca66f711d52a208303860ca | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-03 | 163 | 21 | 2 | 39181c58387189a815e7b3eb29fbd1dd4ee24d0a | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-03 | 163 | 21 | 2 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.65e-03 | 164 | 21 | 2 | dd60edc48a6089148016c4d02f6826f04b747b78 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.65e-03 | 164 | 21 | 2 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.65e-03 | 164 | 21 | 2 | 4a4c32d242db97216cb345e59865c2c826c8b9f2 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.68e-03 | 165 | 21 | 2 | 1c3709ac9f96ace1f3b28e1f2f15b4a8d65885ca | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.68e-03 | 165 | 21 | 2 | d8df50f5a3b646e8ea13739fdc65ce6f39b4d4d2 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.68e-03 | 165 | 21 | 2 | fbc7d97e6f30975d35c76a7c97947a34cf5975d2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.71e-03 | 166 | 21 | 2 | 59d47c1fca7a8c70f6998f3367a9dbcb9b67966f | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-03 | 166 | 21 | 2 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-03 | 166 | 21 | 2 | 688e3c01ffcec01eb7027df6f3bde8fecfb50479 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.71e-03 | 166 | 21 | 2 | 9e98e6070055bfc780becee52d77830e06b6d854 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_AIM2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.75e-03 | 167 | 21 | 2 | 4c8bb68ee2bf7b794940b34df96f38f3f69507e9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.75e-03 | 167 | 21 | 2 | d26e4cea67177975ba15f393e8521be91e148ac9 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.75e-03 | 167 | 21 | 2 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.81e-03 | 169 | 21 | 2 | 17568e7aacfdcd96c469bae57d5ffad04954e9bd | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 2.81e-03 | 169 | 21 | 2 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.88e-03 | 171 | 21 | 2 | b51bbeacb172e8b5de519ada85543d7ae9914b3c | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.91e-03 | 172 | 21 | 2 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 2.94e-03 | 173 | 21 | 2 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | severe_influenza-Neutrophil|severe_influenza / disease group, cell group and cell class (v2) | 2.94e-03 | 173 | 21 | 2 | 615e266419b9f06e964eff73cb466f05451ba0dd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.94e-03 | 173 | 21 | 2 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.94e-03 | 173 | 21 | 2 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-03 | 174 | 21 | 2 | 321c6cae614d28feeee266eeb3499f2053ab79e0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CD24|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-03 | 174 | 21 | 2 | 3e29d620b7b4ab1915ddac70ee5a50d09072292b | |
| ToppCell | severe_influenza-Neutrophil|World / disease group, cell group and cell class (v2) | 2.98e-03 | 174 | 21 | 2 | f9f07436b7d3f190800cd85d229f007032f391e1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-03 | 174 | 21 | 2 | cc4c7f00a25a7814b52d4599166615daa140cc31 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-03 | 175 | 21 | 2 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-03 | 175 | 21 | 2 | 26bd957498e41a3f1ffa60d3effa27ca8c4ba631 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-03 | 175 | 21 | 2 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-03 | 175 | 21 | 2 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-03 | 175 | 21 | 2 | 5a9160a9d05e01d945e77fd81bb0bd87139545cd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-03 | 175 | 21 | 2 | 11f49f00e000cbc137e3540a6d6805cde21d96e6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-03 | 175 | 21 | 2 | 9d797888edb39fd12fd9cfc698a42b7bed19a5b5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-03 | 176 | 21 | 2 | 23f930dac5247ea6d4124da33933d61ad6e089af | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-03 | 176 | 21 | 2 | 322259a35f5c97d73ce7f75835dcdb5c954c91f8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-03 | 176 | 21 | 2 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.04e-03 | 176 | 21 | 2 | bfea433544c6d6b8ad55e50ca94c5574460c2e0b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-03 | 176 | 21 | 2 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-03 | 176 | 21 | 2 | 4843af68f013732c28a8b8edad30d5fa0f2b084b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-03 | 176 | 21 | 2 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.04e-03 | 176 | 21 | 2 | 3c78dee7e1111a579fde6d401b9ecb4d5b8e782f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-03 | 176 | 21 | 2 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.08e-03 | 177 | 21 | 2 | 4f88ea4cfcfa8a9af5a14ab6f6be3b2aa015852e | |
| Drug | beta-damascenone | 9.86e-07 | 24 | 19 | 3 | ctd:C075388 | |
| Drug | YM 155 | 9.88e-06 | 6 | 19 | 2 | ctd:C523798 | |
| Drug | afatinib | 1.38e-05 | 7 | 19 | 2 | ctd:C522924 | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 5887_UP | |
| Drug | Droperidol [548-73-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 5690_UP | |
| Drug | Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 3326_UP | |
| Drug | 1-(2-chlorobenzyl)-5'-phenyl-3'H-spiro(indoline-3,2'-(1,3,4)thiadiazol)-2-one | 5.84e-04 | 43 | 19 | 2 | ctd:C569107 | |
| Drug | Phytic Acid | 6.39e-04 | 45 | 19 | 2 | ctd:D010833 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 1.49e-08 | 8 | 20 | 3 | DOID:0060308 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.08e-06 | 152 | 20 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | corpus collosum mid-posterior volume measurement | 1.30e-04 | 25 | 20 | 2 | EFO_0010300 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 3.70e-04 | 42 | 20 | 2 | DOID:612 (is_implicated_in) | |
| Disease | atopic eczema | 6.30e-04 | 252 | 20 | 3 | EFO_0000274 | |
| Disease | urate measurement, spine bone mineral density | 7.05e-04 | 58 | 20 | 2 | EFO_0004531, EFO_0007701 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.14e-03 | 74 | 20 | 2 | DOID:3748 (is_marker_for) | |
| Disease | Colonic Neoplasms | 4.71e-03 | 152 | 20 | 2 | C0009375 | |
| Disease | Malignant tumor of colon | 5.14e-03 | 159 | 20 | 2 | C0007102 | |
| Disease | atopic asthma | 7.94e-03 | 199 | 20 | 2 | EFO_0010638 | |
| Disease | Neoplasm Metastasis | 9.37e-03 | 217 | 20 | 2 | C0027627 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGCAGHCSTYGHLCR | 956 | Q9BZ76 | |
| HHCCPGCGYFCTAGT | 491 | Q96KQ7 | |
| YGCGHRGCGDGCCCP | 26 | Q3LHN2 | |
| YCCFTPSGHHCFCRT | 166 | Q96NT3 | |
| VCHLCHPNCTYGCTG | 616 | P00533 | |
| FSGCSHPCSGHCGGH | 326 | Q96PV7 | |
| CHNHLGGFYCSCRAG | 156 | O00187 | |
| GCCSSGGGGCCLSHH | 66 | Q5T7P3 | |
| GCCSSGGGGCCLSHH | 66 | Q5T751 | |
| GCCSSGGGGCCLSHH | 66 | Q5T753 | |
| GCCSSGGGGCCLSHH | 66 | Q5T754 | |
| SCYGCGYGCIHSTHC | 16 | Q3LHN1 | |
| GYGCIHSTHCGCNGY | 21 | Q3LHN1 | |
| CPGHCSSYGSICHNG | 956 | Q8WYK1 | |
| PGCAGHCSTYGHLCR | 956 | Q96NU0 | |
| TCHCHCPPGYTGRYC | 246 | A5D8T8 | |
| TCHCHCPPGYTGRYC | 246 | Q6UXF7 | |
| TCHCHCPPGYTGRYC | 246 | Q8NCF0 | |
| GFHHCCFECVPCGAG | 511 | Q7RTX1 | |
| CDCTPGFHCLGAGCS | 86 | Q07011 | |
| CGHPCPGSCHSCFEG | 1441 | Q9P2E3 | |
| PHNPAGCSSCFCYGH | 471 | Q9Y6N6 |